What Is a G6PD Blood Test Used for in Malaria Treatment?

A G6PD blood test measures the activity of a specific enzyme in your red blood cells. When treating certain types of malaria (Plasmodium vivax or Plasmodium ovale), doctors use a radical cure approach to destroy dormant parasites in the liver ^[1]. However, the medications used for this—primaquine and tafenoquine—can cause severe red blood cell destruction (hemolysis) in people who have a genetic condition called G6PD deficiency ^[2]. Because of this risk, international guidelines require testing your G6PD enzyme levels before prescribing these liver-clearing medications to ensure they are safe for you ^[3].

What is G6PD Deficiency?

G6PD (glucose-6-phosphate dehydrogenase) is an enzyme that helps protect your red blood cells from damage ^[2]. G6PD deficiency is an inherited genetic trait where your body either doesn’t produce enough of this enzyme or it doesn’t work effectively ^[4]. It is not contagious, but because it is genetic, blood relatives may also have the trait.

Most people with G6PD deficiency are healthy and have no daily symptoms. However, their red blood cells are fragile when exposed to sudden “oxidative stress.” The medications used to clear liver parasites act as a major stress trigger, causing the fragile red blood cells to break apart faster than the body can replace them ^[2].

Why This Test is Needed for Malaria

Standard malaria pills only treat the active parasites in your bloodstream, and this initial treatment must always be completed promptly as directed ^[5]. However, P. vivax and P. ovale parasites can leave behind hypnozoites (dormant forms) in your liver that cause the disease to relapse months later ^[6]. To prevent relapses, doctors prescribe 8-aminoquinoline drugs like primaquine or tafenoquine ^[1].

If someone with a G6PD deficiency takes these drugs, they can experience rapid hemolysis ^[2]. Symptoms of severe hemolysis include:

• Dark urine: Destroyed red cells release hemoglobin, turning urine the color of dark tea or cola ^[7].
• Severe anemia symptoms: Extreme fatigue, shortness of breath, dizziness, chest pain, and jaundice (yellowing of the skin and eyes) ^[8].

Emergency Action Plan: If you experience any of these symptoms while taking primaquine, stop taking the medication immediately and seek urgent emergency medical care ^[8]. If you took tafenoquine (a single-dose drug), you must still seek immediate emergency care; tafenoquine has a long half-life and stays in the body for a long time, so prolonged medical support may be needed while the drug slowly clears from your system ^[9].

Important Limitations and Precautions

• Timing of the Test: G6PD tests can sometimes give a falsely reassuring “normal” result if taken during a severe acute malaria attack or soon after a blood transfusion, because young red blood cells temporarily have higher enzyme activity ^[10][11]. Always tell your clinician if you recently had a blood transfusion or active hemolysis.
• Pregnancy and Breastfeeding: Primaquine and tafenoquine are generally avoided or contraindicated during pregnancy because the unborn baby’s G6PD status is unknown and cannot be safely tested. If you are breastfeeding, the infant’s G6PD status must also be evaluated before you can safely take these medications ^[12]. Tell your doctor immediately if you are pregnant, planning to conceive, or breastfeeding.

How Your Results Guide Treatment

Modern G6PD testing often provides a quantitative test result, meaning it gives an exact percentage of enzyme activity rather than a simple “pass/fail” ^[13]. This is especially important for women, who can have “intermediate” levels of deficiency that basic screening tests might miss ^[14][15].

Your treatment plan will depend on your specific enzyme activity score, which is usually compared to a local normal median:

• Normal Activity (Usually >70%): Both primaquine and tafenoquine are generally considered safe options for a radical cure ^[3].
• Intermediate Activity (Usually 30% to 70%): Tafenoquine is contraindicated (not allowed) ^[3]. Standard daily primaquine is also generally avoided. Under strict specialist supervision, some guidelines allow a modified, weight-based dose of primaquine taken once a week for 8 weeks ^[4][16]. This weekly regimen is not universally safe, can still cause hemolysis, and requires close medical monitoring ^[17].
• Severe Deficiency (Usually <30%): Standard primaquine and tafenoquine are unsafe and contraindicated ^[4]. Your doctor will discuss alternative ways to manage your malaria risk. Never attempt to alter or select a medication regimen yourself.